Core Viewpoint - Baxter International, Inc. is facing a class action lawsuit due to allegations of systemic defects in its Novum IQ Large Volume Pump, which resulted in serious patient risks and a significant drop in stock price following the announcement of a pause in shipments [3][4]. Group 1: Class Action Lawsuit Details - The class action lawsuit is titled Electrical Workers Pension Fund, Local 103, I.B.E.W. v. Baxter International, Inc., and covers purchasers of Baxter common stock from February 23, 2022, to July 30, 2025 [1]. - Investors have until December 15, 2025, to seek appointment as lead plaintiff in the lawsuit [1]. - The lawsuit alleges that Baxter made false or misleading statements regarding the safety and functionality of its Novum LVP, which led to malfunctions and patient risks [3]. Group 2: Allegations Against Baxter - Specific allegations include that Baxter was aware of multiple malfunctions and injuries related to the Novum LVP but failed to adequately address these issues [3]. - The lawsuit claims that Baxter's customer alerts were insufficient and that design flaws persisted, leading to serious harm [3]. - Following Baxter's announcement on July 31, 2025, to pause shipments of the Novum LVP, the company's stock price fell by more than 22% [4]. Group 3: Legal Process and Representation - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Baxter common stock during the class period to seek lead plaintiff status [5]. - The lead plaintiff will represent the interests of all class members and can select a law firm to litigate the case [5]. Group 4: Company Background - Robbins Geller Rudman & Dowd LLP is a leading firm in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [6]. - The firm has a strong track record, including securing the largest securities class action recovery in history at $7.2 billion in the Enron case [6].

Core Viewpoint - James Hardie Industries plc is under investigation for potential violations of federal securities laws, which may impact investors who have incurred losses [1] Investigation Details - The investigation is initiated by the Law Offices of Frank R. Cruz on behalf of investors [1] - The specific disclosure that triggered the investigation occurred on August 19, 2025 [1]

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz continues its investigation of Stride, Inc. ("Stride†or the "Company†) (NYSE: LRN) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON STRIDE, INC. (LRN), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On September 14, 2025, Simply Wall St. published a report stating that the Gallup-M. ...

Core Viewpoint - Stride, Inc. is under investigation for potential violations of federal securities laws following a significant drop in stock price due to enrollment issues and poor customer experiences related to platform upgrades [1][3][5]. Company Overview - Stride, Inc. is an education technology company that provides an online platform for students across the U.S. [3]. Investigation Details - The investigation is led by Bleichmar Fonti & Auld LLP, a prominent securities law firm, focusing on potential securities fraud related to Stride's statements about record demand for its products and services [1][2][3]. - Stride's claims of continued investment in its career platform and programs are now being scrutinized in light of the recent developments [3]. Stock Performance - On October 28, 2025, Stride disclosed that its growth rate did not meet expectations due to poorly executed upgrades, which led to a "poor customer experience" and increased withdrawal rates [5]. - The company estimated a loss of approximately 10,000 to 15,000 enrollments, resulting in a muted outlook compared to previous years [5]. - Following this announcement, Stride's stock price plummeted over 50% during trading on October 29, 2025 [5].

NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against DexCom, Inc. (“DexCom” or “the Company”) (NASDAQ: DXCM) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired DexCom securitie ...

Core Viewpoint - A class action securities fraud lawsuit has been filed against Hims & Hers Health, Inc. to recover losses for shareholders affected by alleged fraud between April 29, 2025, and June 22, 2025 [2][3] Group 1: Lawsuit Details - The lawsuit alleges that Hims & Hers Health, Inc. engaged in deceptive practices by promoting and selling illegitimate versions of Wegovy®, which posed risks to patient safety [3] - The complaint suggests that these actions created a substantial risk of termination of the company's collaboration with Novo Nordisk [3] - As a result of these allegations, the positive statements made by the defendants regarding the company's business and prospects were deemed materially misleading [3]

Core Viewpoint - A class action securities fraud lawsuit has been filed against Savara Inc. by Pomerantz LLP, correcting a previous statement regarding the filing firm [1][2]. Group 1: Lawsuit Details - The lawsuit seeks to recover losses for shareholders affected by alleged securities fraud occurring between March 4, 2024, and May 23, 2025 [2]. - The complaint alleges that Savara Inc. made false statements regarding the MOLBREEVI Biologics License Application (BLA) for the treatment of pulmonary alveolar proteinosis, indicating insufficient information about its chemistry, manufacturing, and controls [3]. - It is claimed that the FDA was unlikely to approve the MOLBREEVI BLA in its current form, which would delay the submission timeline previously communicated to investors [3]. Group 2: Implications for Investors - The delay in regulatory approval for MOLBREEVI increases the likelihood that Savara would need to raise additional capital, impacting shareholder value [3]. - Shareholders who suffered losses during the relevant timeframe are encouraged to seek recovery, with no cost or obligation to participate [4]. Group 3: Legal Representation - Levi & Korsinsky LLP is highlighted as a nationally recognized securities litigation firm with a strong track record in securing recoveries for shareholders [5]. - The firm has been consistently ranked among the top securities litigation firms in the United States, emphasizing its expertise in complex securities cases [5].

Core Viewpoint - A class action securities fraud lawsuit has been filed against KBR, Inc. by The Rosen Law Firm, P.A., correcting a previous misstatement regarding the filing firm [1][2]. Group 1: Lawsuit Details - The lawsuit seeks to recover losses for shareholders affected by alleged securities fraud occurring between May 6, 2025, and June 19, 2025 [2]. - The complaint alleges that KBR, Inc. made false statements regarding its partnership with HomeSafe, despite knowing that the U.S. Department of Defense had concerns about HomeSafe's ability to fulfill a global household goods contract [3]. Group 2: Next Steps for Affected Shareholders - Shareholders who suffered losses during the specified timeframe are encouraged to visit a provided link to learn about their rights to seek recovery, with no cost or obligation to participate [4]. Group 3: Legal Representation - Levi & Korsinsky LLP is highlighted as a nationally-recognized securities litigation firm with a strong track record in securing recoveries for shareholders, having ranked in the Top 50 Report for seven consecutive years [5].

Core Viewpoint - A class action securities fraud lawsuit has been filed against Fortinet, Inc. to recover losses incurred by shareholders due to alleged misrepresentations regarding the company's product refresh cycle and its impact on business performance [1][2][3]. Group 1: Lawsuit Details - The lawsuit seeks to recover losses for shareholders affected by alleged securities fraud occurring between November 8, 2024, and August 6, 2025 [2]. - The complaint alleges that Fortinet's management made false statements and concealed critical information about the refresh cycle of their products, indicating it would not be as profitable as claimed [3]. - It is claimed that Fortinet misrepresented the number of FortiGate firewalls eligible for upgrades and that the refresh was pushed through much faster than communicated to investors [3]. Group 2: Legal Representation - Levi & Korsinsky LLP, a well-established securities litigation firm, is representing the plaintiffs in this case, having a strong track record in securing significant recoveries for shareholders [5]. - The firm has been recognized in the Top 50 Report by ISS Securities Class Action Services for seven consecutive years, highlighting its expertise in complex securities litigation [5].

Core Viewpoint - A class action securities fraud lawsuit has been filed against Fluor Corporation, alleging that the company made false statements regarding its financial health and project costs, which negatively impacted shareholders [1][3]. Group 1: Lawsuit Details - The lawsuit seeks to recover losses for shareholders affected by alleged securities fraud occurring between February 18, 2025, and July 31, 2025 [2]. - The complaint claims that Fluor Corporation concealed rising costs associated with infrastructure projects due to subcontractor errors, price increases, and scheduling delays [3]. - It is alleged that the company's financial guidance for FY 2025 was unreliable, overstating the effectiveness of its risk mitigation strategies and understating the impact of economic uncertainty [3]. Group 2: Next Steps for Affected Shareholders - Shareholders who suffered losses during the specified timeframe are encouraged to seek information on their rights to recovery, with no cost or obligation to participate [4]. Group 3: Legal Representation - Levi & Korsinsky LLP, a recognized securities litigation firm, is representing the plaintiffs and has a strong track record in securing recoveries for shareholders [5].